Large Employers Planning to Tightly Manage Employee Use of Expensive Drugs

More than half of large employers in 2016 will aim to more tightly manage employees ' use of high-priced specialty drugs, one of the fastest-growing expenses in their health plans. Despite those efforts, companies still expect the cost of specialty drugs that are carefully administered to treat conditions such as cancer, HIV and hepatitis C to continue rising at a double-digit annual rate � well ahead of the pace for traditional pharmacy drugs or companies ' overall spending on health benefits, according to the National Business Group on Health. The group released a survey that found 55% of employers next year plan to direct employees to specialty pharmacies if they need drugs that can cost thousands of dollars for a single treatment. That share was up from a third in the group 's survey a year ago on companies ' plans for 2015 health plans.

Popular Articles

Verifile wins the prestigious Queen’s Award for Enterprise 2019!

Today, I am thrilled to announce that Verifile has been awarded the Queen’s Award for Enterprise in the category of International Trade. Our award recognises the outstanding growth in our overseas sales over the past six years.

Verifile: Background Screening and CV Verification Service

Mind the gap: Beating the CV fraudsters

Dressed up credentials topped with a liberal smattering of sugar-coated qualifications are paying off for the 7.5 million who have confessed to telling more than a white lie or two when it comes to their CVs, Eyal Ben-Cohen founder of Verifile explains.